Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 28, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - April 28, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/14 - iGrow Hair Growth System Attains FDA Over-the-Counter Clearance [Professional Services Close - Up]
Apira Science said that the FDA has granted the company over-the- counter clearance for its iGrow Hair Growth System to effectively promote hair growth in women with Fitzpatrick skin phototypes I to IV and with Ludwig Baldness Scale Classifications of I to II. "More than 40 million women suffer from genetic hair loss, yet iGrow is one of just a ha
12/31/14 - USP Highlights Expertise Offered to Federal Agencies in 2014
USP offered the Federal Trade Commission and FDA background information on the manner in which chemical and biologic drugs are named, also underscoring to FDA that compendial identity is different from regulatory identity. USP encouraged FDA to allow for alternative approaches to validation of analytical procedures and methods:' USP values its role
12/31/13 - OphthaliX to Retrospectively Analyze Phase III Dry Eye Syndrome Study Data Based on A3 Adenosine Receptor Biomarker
PETACH TIKVA, Israel, Dec. 31, 2013/ PRNewswire/ Can-Fite BioPharma Ltd.,, a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today the following:. The Company's subsidiary, OphthaliX Inc., will conduct a retrospective analysis of its Phase III Dry Eye Syndrome stud
12/30/15 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2015. The following discussion and analysis should be read with the financial statements and accompanying notes included elsewhere in this Form 10- Q and in the Annual Report on Form 10- K for the year ended March 31, 2015. Without limiting the broader description of forward-looking statements above, we spec
12/30/15 - Nutra Pharma Letter to Shareholders
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, has publishe
12/30/15 - Valeant Announces New U.S. Fulfillment Agreements With Walgreens; Plans To Further Extend Distribution To Independent Pharmacies
By a News Reporter-Staff News Editor at Biotech Week Valeant Pharmaceuticals International, Inc. announced new fulfillment agreements with Walgreens while indicating it intends to extend this distribution model to additional participating independent retail pharmacies. In conjunction with the fulfillment agreement, Valeant will reduce prices of..
12/30/14 - AVACEN Medical Launches $2 Million CrowdFunder.com Campaign in Response to Positive Fibromyalgia Study Results
AVACEN Medical announced today that it has launched a $2 million campaign on Crowdfunder.com to support further company clinical trials and FDA applications. The research studies evaluated an investigational device that is not cleared by the FDA for the treatment of fibromyalgia. Pre- and post-treatment evaluations were conducted at the UCSD Pain
12/30/14 - Consumer Reports' Survey Finds Americans Mistaken About Safety and Effectiveness of Weight-Loss Supplements
The Consumer Reports survey goes further to uncover consumer confusion about the safety and effectiveness of these products with 20% of respondents saying they thought that the FDA tests and guarantees the safety and effectiveness of supplements. In fact, the FDA regulates supplements much like foods, meaning they're generally considered safe unles
12/30/14 - OTC Daily Alert Stock Watch - Aoxing Pharmaceutical Company, Inc. (NYSE: AXN)
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com. Today's alerts include: Aoxing Pharmaceutical Company, Inc.; last trade. 31 Aox
12/30/14 - OTC Daily Alert Stock Watch - Bristol-Myers Squibb (NYSE:BMY)
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Bristol-Myers Squibb; last trade 59.84 Bristol-Myers Squibb is a global pharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over ser
12/30/14 - OTC Daily Alert Stock Watch - Catalyst Pharmaceuticals (NASDAQ: CPRX)
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Catalyst Pharmaceuticals; last trade 2.92 Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseas
12/30/14 - OTC Daily Alert Stock Watch - Cellceutix (OTC: CTIX)
Today's alerts include: Cellceutix; last trade 4.21 Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol "CTIX". Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antimicrobial applications. Cellceutix's anti-cancer drug Kevetrin is...
12/30/14 - OTC Daily Alert Stock Watch - Columbia Laboratories, Inc (NASDAQ: CBRX)
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Columbia Laboratories, Inc; last trade 5.60 Columbia Laboratories, Inc. is a pharmaceutical development company providing formulation development, clinical trial manufacturing, and advanced analytical
12/30/14 - OTC Daily Alert Stock Watch - Dynavax, (Nasdaq: DVAX)
New York, NY December 29, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Dynavax,; last trade 16.16 Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory dise
12/30/14 - OTC Daily Alert Stock Watch - Impax Laboratories, Inc. (NASDAQ: IPXL)
Today's alerts include: Impax Laboratories, Inc.; last trade 31.84 Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded..
12/30/14 - USP Highlights Expertise Offered to Federal Agencies in 2014
?USP offered the Federal Trade Commission and FDA background information on the manner in which chemical and biologic drugs are named, also underscoring to FDA that compendial identity is different from regulatory identity. "?USP encouraged FDA to allow for alternative approaches to validation of analytical procedures and methods:" USP values
12/30/14 - WALGREEN CO - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Walgreens is principally a retail drugstore chain that sells prescription and non-prescription drugs and general merchandise. At November 30, 2014, we operated 8,330 locations in 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Total locations do not include 430 Healthcare Clinics and 46 worksite pharmacies, which oper
12/30/13 - Acura Pharmaceuticals Secures $10.0 Million of Debt Financing
Acura Pharmaceuticals, Inc. entered into a Loan and Security Agreement with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million. About Acura Pharmaceuticals Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercializatio
12/30/13 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 68854) - Hearing
EVENT: Health and Human Services Department; Food and Drug Administration holds a hearing to obtain information on the formulation, manufacturing, and labeling of currently marketed over-the-counter emergency first aid eyewash drug products, including the components of these products, and the conditions under which such products are safe and effect
12/29/16 - Botanical Drug Development; Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry entitled "Botanical Drug Development." This guidance describes FDA's current thinking on appropriate development plans for botanical drugs to be submitted in new drug applications and specific recommendations for submitting investigational new drug..
12/29/16 - Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings
Dannex Limited, a manufacturer and distributor of pharmaceutical products, has acquired a 53.47% stake in Ayrton Drug Manufacturing Limited, a manufacturer and seller of pharmaceutical and healthcare products, from Adcock Ingram Holdings, Ltd. Dannex and Ayrton are based in Ghana. Adcock is a manufacturer, marketer and distributor of a range of hea
12/29/16 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Item5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Ce
12/29/15 - Global Wearable Medical Devices Market Growing by Leaps and Bounds at 16.40% CAGR 2013-2019
Developing at an impressive CAGR of 16.40% from 2013 to 2019, the wearable medical devices market is only going to expand over the next coming years, according to Transparency Market Research. A new report by the market intelligence company states that the global wearable medical devices market is projected to grow from a value of US $2 bn in 2012
12/29/14 - iGrow Hair Growth System Receives FDA Over-the-Counter Clearance for Women
By a News Reporter-Staff News Editor at Clinical Trials Week Apira Science, Inc. announced the FDA has granted the company over-the-counter clearance for its iGrow Hair Growth System to effectively promote hair growth in women with Fitzpatrick skin phototypes I to IV and with Ludwig Baldness Scale Classifications of I to II. "More than 40 mil
12/29/14 - Strategic Science and Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S. Commercial Rights to Topical...
Strategic Science and Technologies Signs Partnership Agreement with a Leading Global Pharmaceutical Company for U.S. By a News Reporter-Staff News Editor at Clinical Trials Week Strategic Science and Technologies LLC announced the signing of an option agreement with one of the world's largest over-the-counter healthcare companies.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415